Jean-Phillippe Combal

Company: Vivet Therapeutics

Job title: Co-Founder & Chief Executive Officer

Seminars:

Panel Discussion: Maximizing Patient Enrollment for Gene Therapy Trials & Strategies for Commercial Success 2:30 pm

Learn effective methods for identifying and enrolling patients in rare disease trials to enhance trial efficiency Discover how to balance recruitment strategies with the need to ensure the therapy’s long-term commercial viability Explore innovative approaches using technology, partnerships, and advocacy groups to boost patient recruitment and retention ratesRead more

day: Day 2- Clinical 2

Early AAV Manufacturing Strategic Decision for Phase 1&2: Alternatives Scenario & Strategic Consideration for Readiness to Phase 3 Commercial 2:15 pm

Strategies for incorporating market needs, pricing, and reimbursement considerations into early development stages What to consider for defining an optimal process approach for phase ½ while integrating phase 3 perspectives, from IP to COGs assumptions Cost and timelines under investor's objectives and competition and potential future-focused partners Common pitfalls and solutions from CDMO for ensuring…Read more

day: Day 1 - Manufacturing 2